Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Journal of Surgical Orthopaedic Advances|March 21, 2007
Hemorrhagic upper extremity complications from tissue plasminogen activatorKathleen A Crick, John C Crick, Michael T PulleyMuscle & Nerve|May 17, 2020
Optimizing telemedicine to facilitate amyotrophic lateral sclerosis clinical trialsRaghav Govindarajan, James D Berry, Sabrina Paganoni, et al.Frontiers in Neurology|March 25, 2021
Individualizing Therapy in CIDP: A Mini-Review Comparing the Pharmacokinetics of Ig With SCIg and IVIgSaid R Beydoun, Khema R Sharma, Bassam A Bassam, et al.Journal of the Neurological Sciences|August 14, 2025
First analysis of the Myasthenia Gravis SPOTLIGHT Registry: outcomes with eculizumab and ravulizumabJames F Howard, Dubravka Dodig, Lida Zeinali, et al.Muscle & Nerve|May 27, 2018
Multidisciplinary amyotrophic lateral sclerosis telemedicine care: The store and forward methodMichael T Pulley, Rebecca Brittain, Wayne Hodges, et al.JMIR Research Protocols|November 7, 2025
Acute Adenosine Receptor Antagonism in Combination With Acute Intermittent Hypoxia to Promote Breathing Plasticity in Amyotrophic Lateral Sclerosis: Protocol for a Randomized, Double-Blinded, Placebo-Controlled TrialPriscila Sales de Campos, May Smith-Hublou, Wendy L Olsen, et al.The Lancet. Neurology|January 25, 2025
Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trialAli A Habib, Chongbo Zhao, Inmaculada Aban, et al.Neurology|August 13, 2017
Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective reviewMichael K Hehir, Lisa D Hobson-Webb, Michael Benatar, et al.Neurology|October 21, 2022
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia GravisVera Bril, Andrzej Szczudlik, Antanas Vaitkus, et al.Muscle & Nerve|December 22, 2018
Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravisKatherine M Clifford, Lisa D Hobson-Webb, Michael Benatar, et al.Pageof 2